Phase II Clinical Trial to Investigate the Efficacy, Safety and Pharmacokinetics of YH14617 After Once Weekly or Biweekly Administration in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 25 Feb 2015
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Yuhan
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2014 Planned End Date changed from 1 Jul 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.